This bill significantly amends the Controlled Substances Act by introducing new registration requirements for opioid treatment programs, aiming to enhance community input and ensure programs effectively serve patients while minimizing negative local impacts. New conditions include prohibiting programs within a half-mile of sensitive areas like schools or playgrounds, and requiring justification of patient need within the specific community. Programs must actively promote telehealth services, designate a community liaison, and engage with local government systems to track service requests related to drug abuse. A core provision mandates extensive community impact considerations , requiring outreach to stakeholders, developing a neighborhood engagement plan, and establishing a community advisory board with local volunteers. Furthermore, programs must implement a community relations plan to measure and minimize negative impacts, such as loitering or improper needle disposal, and to resolve quality-of-life issues. The legislation also requires opioid treatment programs to report detailed treatment performance measurement data , including patient engagement in long-term addiction treatment and telehealth effectiveness, with the Secretary submitting annual reports to Congress.